InfuSystem (NYSE:INFU – Get Free Report) and Privia Health Group (NASDAQ:PRVA – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings.
Profitability
This table compares InfuSystem and Privia Health Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| InfuSystem | 1.12% | 2.78% | 1.41% |
| Privia Health Group | 1.19% | 3.52% | 2.00% |
Earnings & Valuation
This table compares InfuSystem and Privia Health Group”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| InfuSystem | $143.34 million | 1.89 | $870,000.00 | $0.41 | 32.68 |
| Privia Health Group | $2.12 billion | 1.36 | $22.92 million | $0.21 | 107.24 |
Privia Health Group has higher revenue and earnings than InfuSystem. InfuSystem is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
InfuSystem has a beta of 1.49, meaning that its share price is 49% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500.
Insider & Institutional Ownership
71.1% of InfuSystem shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 10.8% of InfuSystem shares are owned by company insiders. Comparatively, 5.7% of Privia Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Analyst Recommendations
This is a summary of recent ratings for InfuSystem and Privia Health Group, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| InfuSystem | 0 | 0 | 2 | 0 | 3.00 |
| Privia Health Group | 0 | 3 | 11 | 0 | 2.79 |
InfuSystem presently has a consensus target price of $17.50, suggesting a potential upside of 30.60%. Privia Health Group has a consensus target price of $31.00, suggesting a potential upside of 37.66%. Given Privia Health Group’s higher probable upside, analysts clearly believe Privia Health Group is more favorable than InfuSystem.
Summary
Privia Health Group beats InfuSystem on 8 of the 14 factors compared between the two stocks.
About InfuSystem
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
About Privia Health Group
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.
